Biblio

Export 1191 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is D  [Clear All Filters]
2022
S. Cardoso, Silva, D., Alves, L., Guerreiro, M., and de Mendonça, A., The Outcome of Patients with Amyloid-Negative Amnestic Mild Cognitive Impairment., J Alzheimers Dis, vol. 86, no. 2, pp. 629-640, 2022.
Y. Dou, Liu, S., Li, Y., Wu, H., Chen, H., and Ji, Y., Plasma Cholesterol Levels as Potential Nutritional Biomarkers for Lewy Body Dementia., J Alzheimers Dis, vol. 86, no. 2, pp. 779-786, 2022.
J. R. Wright, Deen, Q. Fahm E., Stevenson, A., Telford-Cooke, L., Parker, C., Martin-Ruiz, C., Steinert, J. R., Kalaria, R. N., and Mukaetova-Ladinska, E. B., Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease., J Alzheimers Dis, vol. 89, no. 4, pp. 1483-1492, 2022.
Y. - Y. Huang, Chen, S. - D., Leng, X. - Y., Kuo, K., Wang, Z. - T., Cui, M., Tan, L., Wang, K., Dong, Q., and Yu, J. - T., Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management., J Alzheimers Dis, vol. 86, no. 3, pp. 983-999, 2022.
F. K. Kok, van Leerdam, S. L., and de Lange, E. C. M., Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology., J Alzheimers Dis, vol. 87, no. 1, pp. 51-81, 2022.
S. Hendriks, Peetoom, K., Tange, H., van Bokhoven, M. A., van der Flier, W. M., Bakker, C., Papma, J. M., Koopmans, R., Verhey, F., Köhler, S., and de Vugt, M., Pre-Diagnostic Symptoms of Young-Onset Dementia in the General Practice up to Five Years Before Diagnosis., J Alzheimers Dis, vol. 88, no. 1, pp. 229-239, 2022.
L. Agüera-Ortiz, Babulal, G. M., Bruneau, M. - A., Creese, B., D'Antonio, F., Fischer, C. E., Gatchel, J. R., Ismail, Z., Kumar, S., McGeown, W. J., Mortby, M. E., Nuñez, N. A., de Oliveira, F. F., Pereiro, A. X., Ravona-Springer, R., Rouse, H. J., Wang, H., and Lanctôt, K. L., Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions., J Alzheimers Dis, vol. 88, no. 4, pp. 1203-1228, 2022.
L. Agüera-Ortiz, Babulal, G. M., Bruneau, M. - A., Creese, B., D'Antonio, F., Fischer, C. E., Gatchel, J. R., Ismail, Z., Kumar, S., McGeown, W. J., Mortby, M. E., Nuñez, N. A., de Oliveira, F. F., Pereiro, A. X., Ravona-Springer, R., Rouse, H. J., Wang, H., and Lanctôt, K. L., Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions., J Alzheimers Dis, vol. 88, no. 4, pp. 1203-1228, 2022.
M. Vassilaki, Crowson, C. S., Iii, J. M. Davis, Duong, S. Q., Jones, D. T., Nguyen, A., Mielke, M. M., Vemuri, P., and Myasoedova, E., Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging., J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
H. Kim, Levine, A., Cohen, D., Gehrman, P., Zhu, X., Devanand, D. P., Lee, S., and Goldberg, T. E., The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks., J Alzheimers Dis, vol. 87, no. 4, pp. 1567-1580, 2022.
R. Piccarducci, Caselli, M. Chiara, Zappelli, E., Ulivi, L., Daniele, S., Siciliano, G., Ceravolo, R., Mancuso, M., Baldacci, F., and Martini, C., The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy., J Alzheimers Dis, vol. 89, no. 3, pp. 1039-1049, 2022.
X. Hua, Church, K., Walker, W., L'Hostis, P., Viardot, G., Danjou, P., Hendrix, S., and Moebius, H. J., Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial., J Alzheimers Dis, vol. 86, no. 3, pp. 1399-1413, 2022.
C. Contini, Serrao, S., Manconi, B., Olianas, A., Iavarone, F., Bizzarro, A., Masullo, C., Castagnola, M., Messana, I., Diaz, G., and Cabras, T., Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging., J Alzheimers Dis, vol. 89, no. 2, pp. 605-622, 2022.
A. E. Weller, Ferraro, T. N., Doyle, G. A., Reiner, B. C., Crist, R. C., and Berrettini, W. H., Single Nucleus Transcriptome Data from Alzheimer's Disease Mouse Models Yield New Insight into Pathophysiology., J Alzheimers Dis, vol. 90, no. 3, pp. 1233-1247, 2022.
J. M. Walker, Dehkordi, S. Kazempour, Schaffert, J., Goette, W., Iii, C. L. White, Richardson, T. E., and Zare, H., The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals., J Alzheimers Dis, vol. 91, no. 2, pp. 683-695, 2022.
N. Krishnadas, Huang, K., Schultz, S. A., Doré, V., Bourgeat, P., M Y Goh, A., Lamb, F., Bozinovski, S., Burnham, S. C., Robertson, J. S., Laws, S. M., Maruff, P., Masters, C. L., Villemagne, V. L., and Rowe, C. C., Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease., J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
2023
J. Lilek, Ajroud, K., Feldman, A. Z., Krishnamachari, S., Ghourchian, S., Gefen, T., Spencer, C. L., Kawles, A., Mao, Q., Tranovich, J. F., Jack, C. R., Mesulam, M. - M., R Reichard, R., Zhang, H., Murray, M. E., Knopman, D., Dickson, D. W., Petersen, R. C., Smith, B., Ashe, K. H., Mielke, M. M., Nelson, K. M., and Flanagan, M. E., Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 1, pp. 241-260, 2023.
N. Ortí-Casañ, Wajant, H., H Kuiperij, B., Hooijsma, A., Tromp, L., Poortman, I. L., Tadema, N., de Lange, J. H. E., Verbeek, M. M., De Deyn, P. P., Naudé, P. J. W., and Eisel, U. L. M., Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2., J Alzheimers Dis, vol. 94, no. 3, pp. 977-991, 2023.
N. Ortí-Casañ, Wajant, H., H Kuiperij, B., Hooijsma, A., Tromp, L., Poortman, I. L., Tadema, N., de Lange, J. H. E., Verbeek, M. M., De Deyn, P. P., Naudé, P. J. W., and Eisel, U. L. M., Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer's Disease Mouse Model with Humanized TNF Receptor 2., J Alzheimers Dis, vol. 94, no. 3, pp. 977-991, 2023.
C. Milano, Hoxhaj, D., Del Chicca, M., Pascazio, A., Paoli, D., Tommasini, L., Vergallo, A., Pizzanelli, C., Tognoni, G., Nuti, A., Ceravolo, R., Siciliano, G., Hampel, H., and Baldacci, F., Alzheimer's Disease and Neurosyphilis: Meaningful Commonalities and Differences of Clinical Phenotype and Pathophysiological Biomarkers., J Alzheimers Dis, vol. 94, no. 2, pp. 611-625, 2023.
P. Ding, Gorenflo, M. P., Zhu, X., and Xu, R., Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study., J Alzheimers Dis, vol. 92, no. 3, pp. 989-1000, 2023.
S. Liu, Dashper, S. G., and Zhao, R., Association Between Oral Bacteria and Alzheimer's Disease: A Systematic Review and Meta-Analysis., J Alzheimers Dis, vol. 91, no. 1, pp. 129-150, 2023.
C. E. Franz, Gustavson, D. E., Elman, J. A., Fennema-Notestine, C., Hagler, D. J., Baraff, A., Tu, X. M., Wu, T. - C., De Anda, J., Beck, A., Kaufman, J. D., Whitsel, N., Finch, C. E., Chen, J. - C., Lyons, M. J., and Kremen, W. S., Associations Between Ambient Air Pollution and Cognitive Abilities from Midlife to Early Old Age: Modification by APOE Genotype., J Alzheimers Dis, vol. 93, no. 1, pp. 193-209, 2023.
R. Mc Ardle, Hamilton, C., Del Din, S., Kingston, A., Robinson, L., Galna, B., Thomas, A. J., and Rochester, L., Associations Between Local Area Deprivation and Physical Activity Participation in People with Cognitive Impairment in the North East of England., J Alzheimers Dis, vol. 95, no. 1, pp. 265-273, 2023.
K. J. Edmunds, Driscoll, I., Hagen, E. W., Barnet, J. H., Ravelo, L. A., Plante, D. T., Gaitán, J. M., Lose, S. R., Motovylyak, A., Bendlin, B. B., Okonkwo, O. C., and Peppard, P. E., Cardiorespiratory Fitness Attenuates the Deleterious Effects of Sleep Apnea on Cerebral Structure and Perfusion in the Wisconsin Sleep Cohort Study., J Alzheimers Dis, vol. 95, no. 2, pp. 427-435, 2023.

Pages